Topical steroid cream leads to improved treatment for cancer patients

December 10, 2014

Researchers have shown how a topical steroid cream frequently used  to treat common skin conditions, can be used to improve dermatitis in cancer patients.

Radiotherapy uses X-rays to destroy cancer cells but this can often lead to a severe skin reaction involving redness, pain and blistering similar to sunburn.

The trial of this  cream – mometasone furoate—was so successful that the patients in the research will now be offered this instead of the existing treatment.

Breast patients were recruited from hospitals all over the North West for the trial, based at the Rosemere Cancer Centre at the Royal Preston Hospital.

Dr Andrew Hindley of Rosemere Cancer Centre: "We believe that this treatment should be considered the standard of care when a schedule is administered to an anatomical site where severe dermatitis would be predicted."

The were offered either diprobase cream or mometasone furoate to be administered daily from the start of radiation therapy for 5 weeks and for at least a fortnight afterwards.

Dr Lisa Wood from Lancaster Medical School said: "Mometasone furoate cream significantly reduces radiation dermatitis when applied to the breast during and after radiation therapy. For the first time, we have shown a significantly beneficial effect on quality of life for a topical steroid cream."

The paper was presented at ASTRO, the international conference in the US last year and was one of two highly commended papers at UK Radiation Oncology conference later the same year.

Explore further: Silicone dressings reduce painful skin reactions following radiation for breast cancer, study finds

Related Stories

Silicone dressings reduce painful skin reactions following radiation for breast cancer, study finds

November 1, 2012
(Medical Xpress)—Skin reactions following radiation therapy for breast cancer have been the focus of a recent clinical trial conducted by Dr Patries Herst from the Department of Radiation Therapy, University of Otago, Wellington ...

Skin reactions during radiation therapy preventable

February 12, 2014
Severe skin reactions during radiation therapy could be prevented by applying a thin transparent silicone dressing to the skin from the first day of treatment, clinical research from New Zealand shows.

Most elderly women with early stage breast cancer receive a treatment that may not be as effective

December 8, 2014
A new analysis has found that while clinical trial data support omitting radiation treatments in elderly women with early stage breast cancer, nearly two-thirds of these women continue to receive it. The findings are published ...

Focus on treatment costs, value: Less radiation for elderly women with early breast cancer

September 16, 2014
In a healthcare climate where the costs of treatment are increasingly weighed against potential benefit, a Yale study has found that radiation oncologists are using fewer or less-aggressive radiation procedures on elderly ...

ASTRO issues second list of 'Choosing wisely' guidelines

September 18, 2014
(HealthDay)—The American Society for Radiation Oncology (ASTRO) has released a second list of five radiation oncology-specific treatments that should be discussed before being prescribed, as part of the national Choosing ...

Anti-cancer drug protects normal cells from radiation damage, increases effectiveness of radiation therapy

November 14, 2014
Although radiation treatments have become much more refined in recent years, it remains a challenge to both sufficiently dose the tumor while sparing the surrounding tissue. A new anti-cancer drug, already in clinical development, ...

Recommended for you

Researchers discover specific tumor environment that triggers cells to metastasize

November 21, 2017
A team of bioengineers and bioinformaticians at the University of California San Diego have discovered how the environment surrounding a tumor can trigger metastatic behavior in cancer cells. Specifically, when tumor cells ...

New study points the way to therapy for rare cancer that targets the young

November 21, 2017
After years of rigorous research, a team of scientists has identified the genetic engine that drives a rare form of liver cancer. The findings offer prime targets for drugs to treat the usually lethal disease, fibrolamellar ...

Clinical trial suggests new cell therapy for relapsed leukemia patients

November 20, 2017
A significant proportion of children and young adults with treatment-resistant B-cell leukemia who participated in a small study achieved remission with the help of a new form of gene therapy, according to researchers at ...

Cell-weighing method could help doctors choose cancer drugs

November 20, 2017
Doctors have many drugs available to treat multiple myeloma, a type of blood cancer. However, there is no way to predict, by genetic markers or other means, how a patient will respond to a particular drug. This can lead to ...

Researchers discover a new target for 'triple-negative' breast cancer

November 20, 2017
So-called "triple-negative" breast cancer is a particularly aggressive and difficult-to-treat form. It accounts for only about 10 percent of breast cancer cases, but is responsible for about 25 percent of breast cancer fatalities.

Study reveals new mechanism used by cancer cells to disarm attacking immune cells

November 20, 2017
A new study by researchers at The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute (OSUCCC - James) identifies a substance released by pancreatic cancer cells that protects ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.